baber/WOPTO huggingface dataset:
Patent NZ-502778-A (NZ)
Title: Chirpless optical pulse transmission through chromatic dispersion compensated optical fibre
Inventor: FRANCO PIERLUIGI
IPC: H04B10/508
Filed: 1998-07-31
Abstract: Soliton or soliton-like optical pulses with characteristics adapted to propagation in an optical line for RZ type transmission are generated by modulating a continuous optical signal (1) by means of a modulator (2) which is substantially devoid of chirping, in which the modulator drive signal comprises at least one frequency (4) and one harmonic (5) thereof superimposed on each other (7). A high-speed optical transmission system is rendered independent of the type of transmitter or of signals sent to it if it comprises an adaptation unit (32) receiving the original optical pulses (30) and capable of generating corresponding pulsed signals (63) of RZ type.
Patent NZ-505129-A (NZ)
Title: Purification of tramadol
Inventor: ARCHER NICHOLAS
IPC: C07C215/42
Filed: 1999-01-14
Abstract: A process for the preparation of Tramadol via Tramadol hydroiodide and/or Tramadol hydrobromide is disclosed. The process involves a Grignard reaction of 2-(dimethylaminomethyl)cyclo-hexanone with the reagent 3-methoxyphenylMgX, where X is a halogen. This forms a crude base, which is then contacted with hydrobromic acid or hydroiodic acid to form a salt, which is re-crystallized to give Tramadol hydroiodide or Tramadol hydrobromide respectively. This final product can then be converted to Tramadol.
Patent NZ-509984-A (NZ)
Title: Process for the production of N-protected azetidine-2-carboxylic acids (AzeOHs)
Inventor: SJOGREN MAGNUS
IPC: C07D205/04
Filed: 1999-08-27
Abstract: N-protected azetidine-2-carboylic acid can be produced by the addition of a base to an aqueous solvent comprising an organic acid addition salt of an azetidine-2-carboxylic acid and then the addition of protecting agent to the resulting mixture. Preferably the organic acid is tartaric acid and the protecting agent provides a tert-butyloxycarbonyl group.
Patent NZ-511193-A (NZ)
Title: Attachment of a bridge and temple hinge to the lens of rimless glasses
Inventor: CONNER WILLIAM A
IPC: G02C1/02
Filed: 1999-10-21
Abstract: Attachment of a bridge (18) and temple hinge (32) to the lens (12) of eye glasses. The attachment is accomplished by providing a pair of apertures (30) of a selected configuration in each lens adjacent to the outer and inner surface of the lens, a bushing (24) conforming to the lens apertures with a tapered aperture through the center thereof from front to back and tapering the distal ends of the bridge and temple hinges. This combination when in place in the lenses apertures provides a friction lock between the lens and the bridge and temple hinge. The taper can be in the range of 1 to 45 degrees. In another embodiment the lens can also have a tapered aperture either convergent from the front to the back of the lens or divergent from the front to the back of the lens. Ideally a taper of 4.5 degrees in the bushing is preferable with less taper in the lens apertures when tapered lens apertures are utilized. The taper can take the form of a frusto conic section, a cylinder, a rectangular or triangular in cross section. The distal ends of the bridge and temple hinge can be inserted either from the front of the lens toward the back or from the back toward the front. The distal ends of the temple hinge can be inserted directly into the aperture within the bushing for attachment or can additionally be bent formed to provide a bias between the outer surface of the lens adjacent the aperture for non rotational support. In some applications a notch is provided at the outer lens surface and the bent formed portion of the temple hinge is nested therein for additional mechanical support and to increase the resistance of relative rotation of the bridge or temple hinge.
Patent NZ-516108-A (NZ)
Title: Ophthalmic composition containing ketotifen and a non-ionic tonicity agent
Inventor: ADAM MARCIA JOHANNA
IPC: A61K47/10
Filed: 2000-07-21
Abstract: An ophthalmic composition useful in the treatment of allergic conjunctivitis consisting essentially of a ketotifen salt in a concentration of 0.01 to 0.04%, a non-ionic tonicity agent in an amount such that the total tonicity of the composition has an osmolarity in the range of 210 to 290 millosmoles, optionally a preservative, and water, wherein said composition has a pH of between 4.4 and 5.8.
Patent NZ-517241-A (NZ)
Title: Non-naturally occurring viral gene therapy vector for cell-specific delivery of a nucleic acid to a target cell
Inventor: ROZENBERG YANINA
IPC: A61K47/48
Filed: 2000-08-18
Abstract: Compositions and methods for gene therapy are provided. In particular, a targeted artificial gene delivery ("TAGD") vehicle is provided, comprising a multifunctional artificial surface moiety surrounding a recombinant viral particle (nucleocapsid) or recombinant core for gene delivery. The figure depicts a schematic diagram for a surface of TAGD particle containing an immunoprotective element (PEG), a fusogenic element (the membrane destabilising peptide) and a cell-binding element (the targeting peptide).
Patent NZ-519763-A (NZ)
Title: Information service station that holds received information from transmission source in an information storage medium to be given to mobile unit
Inventor: ASAMI KAZUO
IPC: H04B7/26
Filed: 2001-03-15
Abstract: An information service station comprises: a) Equipment for receiving a communication from an artificial satellite; b) An information-processing device, wherein the information-processing device has a function to enable transfer of information directly to a mobile station or indirectly via information storage medium (IC card). The equipment and the information processing device are installed so as to be adjacent to a facility selected from one of a gas station, and automobile repair shop, a parking area and a shop. The information-processing device has a function to compare an information object registered on a medium removed from a mobile station and mounted in the media-mounting device with an information object stored in the information-processing device, for determining information to be transmitted to the mobile station.
Patent NZ-525551-A (NZ)
Title: Transdermal drug delivery devices having coated microprotrusions
Inventor: CORMIER MICHEL J N
IPC: A61K38/095
Filed: 2001-10-26
Abstract: A device and method are provided for percutaneous transdermal delivery of a potent pharmacologically active agent. The agent is dissolved in water to form an aqueous coating solution having a viscosity of less than 500 centiposes for coating extremely tiny skin piercing elements. The coating solution is applied to the skin piercing elements using known coating techniques and then dried. The device is applied to the skin of a living animal (e.g., a human), causing the microprotrusions to pierce the stratum corneum and deliver a therapeutically effect dose of the agent to the animal. The drug delivered by such a device is one that is effective when delivered in an amount of less than 1 mg, said agent having aqueous solubility of 50 mg/ml.
Patent NZ-530692-A (NZ)
Title: Flowing bag filling system and bag therefor
Inventor: DEMATTEIS ROBERT B
IPC: B65D30/24
Filed: 2002-06-11
Abstract: A bag having an inwardly disposed seam with a self-sealing opening is disclosed. The bag is formed from a sheet of plastic material with two of the parallel edges of the material joined along a seam formed inwardly of a tube formed from the sheet with internal flap portions. At least two seals are made across the tube to form a four-sided bag. An opening is defined along the seam with an internal flap structure adjacent the opening. Pressure in the interior of the bag acts to cause the internal flap portions to move into a sealed relationship to seal the opening.
Patent NZ-534831-A (NZ)
Title: Carbonylamino-derivatives having histone deacetylase (HDAC) inhibiting enzymatic activity
Inventor: VAN EMELEN KRISTOF
IPC: A61K31/53
Filed: 2003-03-11
Abstract: Disclosed herein are carbonylamino-derivative compounds of formula (I), wherein n, m, t, R1, R2, R3, R4, R5, L, Q, X, Y and A are as defined in the specification, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine, particularly as an anti-cancer agent.
Patent NZ-534891-A (NZ)
Title: Selective dipeptide inhibitors of kallikrein
Inventor: EVANS DAVID MICHAEL
IPC: A61P1/04
Filed: 2003-03-04
Abstract: Disclosed are compounds of formula (I) wherein; R1 is selected from H, lower alkyl, R4-CO, R4-O2CCH2, R5-OCO and R5-SO2; R3 is selected from H, OH, and O-lower alkyl. Further disclosed are pharmaceutical compositions comprising compounds of formula (I); and the use of the compounds of formula (I) in the manufacture of a medicament for use in the treatment of diseases for which over activity of plasma kallikrein is a causative factor; and in the treatment of inflammatory bowel disease, arthritis, inflammation, septic shock, hypotension, cancer, adult respiratory disease syndrome, disseminated intravascular coagulation, cardiopulmonary bypass surgery and bleeding from post-operative surgery.
Patent NZ-535686-A (NZ)
Title: 2-(2,6-Dichlorophenyl)-diarylimidazoles
Inventor: BRANDT MICHAEL
IPC: C07C45/67
Filed: 2003-04-16
Abstract: A compound of the general formula (I), as well as its pharmaceutically acceptable salts, is disclosed. X is hydrogen; OR1; SR2; (SO)R2; or a group A1Q. Y is hydrogen or a group A2-R. Z represents one or two substituents independently selected from the group which includes halogen, hydroxyl, allyloxy, methyl, methoxymethoxy, methylthio, cyano and nitro. The use of an above compound is described to be for the production of a medicament for the treatment of diseases, which are mediated by c-met diseases. Also disclosed is the process for the manufacture of a compound of the general formula (VI) or (VII). The process is characterised by the oxidation of the sulphide group of the thioethers, described by the general formula (V), which are obtained by N-deoxygenation of compounds of the general formula (IV).
Patent NZ-538149-A (NZ)
Title: Three piece basket carrier
Inventor: RICHARD SCHUSTER
IPC: B31B50/86
Filed: 2003-09-10
Abstract: A glued three piece folding basket carrier which has two partitions for dividing the carrier into six cells with each partition being constructed of a different material than used to construct the outside basket carrier. Each partition is glued to a handle panel and a divider flap on the end of the basket carrier and a to a side wall to form a bottle cell with walls that are perpendicular to the divider between the two sides of the carrier and which are also formed as part of the partition
Patent NZ-540308-A (NZ)
Title: A cover for a power cord connection
Inventor: SMITH BRIAN MICHAEL
IPC: H01R13/58
Filed: 2005-05-25
Abstract: A power cord cover which has a housing in which a power plug and a power socket can be joined together and placed within the housing. The housing comprises a first part and a second part which can be opened to allow the power plug and the power socket to be placed within the housing. The first part and/or the second part have internal support members to hold the power plug into engagement with the power socket and to prevent the power plug and power socket from being pulled apart. The housing has a streamlined outer shape to reduce snagging, the streamlined outer shape comprising a main central body portion and opposed nose portions that taper from the main central body portion to a reduced end. Each end contains an opening through which a power lead can pass, the opening containing a resilient annular seal that grips the power lead to prevent the power lead from being pulled out of the plug/socket upon pulling of the power lead. The first part and/or second part configured such that when attached together, the housing is substantially watertight.
Patent NZ-540536-A (NZ)
Title: osteosynthesis plate for the osteosynthesis of small neighbouring bones
Inventor: MARTIN JEAN-JACQUES
IPC: A61B17/80
Filed: 2003-10-22
Abstract: Disclosed is an osteosynthesis plate for the osteosynthesis of small neighbouring bones. The osteosynthesis plate (1) is dimensioned such that it can be positioned above the bones to be treated without resting on the larger neighbouring bones. According to the invention, the osteosynthesis plate comprises lateral holes (16) for the insertion of screws (6) which are used to fix same to the bones (2 to 5). The plate is characterised in that: (i) it comprises a flat face (10) which is intended to come into contact with the bones to be treated; and (ii) it comprises holes (16) for receiving screws (6), which have axes that are inclined in relation to the aforementioned flat face (10) and which are designed such that the inserted screws diverge towards the outside of the plate (1).
Patent NZ-547925-A (NZ)
Title: Sachets and materials used in manufacture of sachets
Inventor: DAVIES HUGH THOMAS HARRY
Filed: 2006-06-14
Abstract: A sachet for storing and dispensing a fluent material, comprises a lamination of first , second and third layers 1, 2, 3. The second layer 2 is a semi-rigid layer located between the first and third layers 1, 3 and includes a line of weakness 20 formed in a mid-portion of the layer. At least a portion of the line of weakness sequentially delineates inter-digitated finger portions of the second layer 2. The finger portions extend in respective substantially opposite directions toward first and second opposing edges of the second layer on opposite sides of the line of weakness 20. The first layer 1 seals over and around the line of weakness 20, and the third layer 3 is fixed to at least one of the first layer 1 or the second layer 2. The sachet is adapted to flex preferentially at the line of weakness 20 on application of a compression force between the first and second edges. The second layer 2 is adapted to open at the line of weakness 20 and move at least the tips of the finger portions away from respective immediately surrounding portions of the second layer by flexure of the second layer 2 at the line of weakness 20. The first layer 1 is adapted to rupture in the vicinity of the line of weakness 20 by movement of at least the tips of the finger portions away from respective immediately surrounding portions of the second layer 2 to form at least one discharge opening through which contents of the sachet may be discharged.
Patent NZ-548769-A (NZ)
Title: C10 cyclopentyl ester substituted taxanes
Inventor: HOLTON ROBERT A
IPC: C07D409/12
Filed: 2005-02-14
Abstract: Disclosed is a taxane having the structure indicated in the drawing, where X3 is thienyl, Ac is acetyl and Bz is benzoyl.
Patent NZ-552940-A (NZ)
Title: Panel particularly for providing explosion-resistant curtain walls
Inventor: FRANCESCHET ALBERTO
IPC: E06B5/12
Filed: 2007-01-30
Abstract: A panel for providing an explosion-resistant curtain wall, is disclosed. The panel comprises one or more glass panes, first and second seats, interconnection means, strengthening means, and limiting means. The glass panes form a glazing unit which is associated at its upper and lower end by at least two crossmembers. First seats are provided in each upright and cross-member, and second seats are provided axially in each upright. Interconnection means are included for strengthening and interconnecting the uprights and cross-members. Strengthening means strengthens and guides the mutual position of two contiguous uprights of two panels arranged one above the other that comprise a male element associable with a the first seat at a lower end of one of the two contiguous uprights and a female element that is associable with the first seat at an upper end of the other contiguous uprights. The limiting means limits the mutual rotation of two contiguous uprights of two panels arranged side by side.
Patent NZ-571133-A (NZ)
Title: Gastric raft composition comprising preferably processed starches for inducing satiety
Inventor: TESTER RICHARD
IPC: A61K9/00
Filed: 2006-03-16
Abstract: Disclosed is a gastric raft composition comprising: a gel forming biopolymer and one or more processed starches, wherein said processed starch integrates with the gel forming biopolymer in the formation of a raft on contacting the gastric raft composition with gastric acid. Also described are methods of modulating appetite in mammals. In particular, methods of inducing satiety in an individual, a method of prolonging retention of a source of dietary energy in the stomach and methods of treatment of diseases characterised by hypoglycaemia, such as glycogen storage disease (GSD), and diseases such as diabetes, gastro-oesophageal reflux disease and for controlling serum glucose levels in an individual.
Patent NZ-583476-A (NZ)
Title: A latchset with a bolt movable by magnetic force
Inventor: WOOD DAVID ANDREW
IPC: E05B47/00
Filed: 2010-02-22
Abstract: A latchset, a door assembly including a latchset, and a method of operating a latchset is disclosed. The latchset includes a first body and a second body where the first body includes a first side and a cavity which extends at least partly into the first body from the first side. The second body includes a first end, a retaining arrangement, and a latch bolt. The latch bolt is transversely movable relative to the first body between a first position at which the bolt extends from the first end and a second position at which the bolt is frictionally engaged with the retaining arrangement. A mechanism is provided by which the bolt is operable from outside of the second body and with which the bolt is movable from the first position to the second position. In use, positioning the first side adjacent the first end results in the bolt moving magnetically from the second position to the first position so that the bolt extends into the cavity.
Patent NZ-583867-A (NZ)
Title: Power generating apparatus from fluid using a bucket with an open and close valve at the bottom
Inventor: PARK JONG-WON
IPC: F03B3/04
Filed: 2008-10-02
Abstract: A power generating apparatus from fluid 1000, comprises a bucket 40 for loading with fluid 1000, an opening-and-shutting valve 20, which is installed at a base of the bucket 40 to control the flow of the fluid 1000 into and out of the bucket 40, a controller connected to the opening-and-shutting valve 20 to control its opening and shutting, a motion converter 30 that converts the rectilinear motion of the bucket 40 into rotary motion, and at least one first connector 45 that connects the bucket 40 to the motion converter 30.
Patent NZ-589214-A (NZ)
Title: Monoclonal antibody SC104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent
Inventor: DURRANT LINDA GILLIAN
IPC: C07K16/44
Filed: 2005-05-11
Abstract: Provided is an antibody or fragment thereof comprising a V L domain wherein the V L domain comprises three CDRs wherein the sequence of CDRI is a specified amino acids sequence or a sequence at least 70% identical thereto, and the sequence of CDR3 is a specified amino acid sequence or a sequence at least 70% identical thereto; and wherein the antibody or fragment thereof binds Colo205 cells. The antibody can be used to treat tumours.
Patent NZ-590704-A (NZ)
Title: Maintaining a detected water flow at a predetermined temperature threshold by adjusting heaters
Inventor: ELLIOTT JEFF
IPC: F24H9/20
Filed: 2007-02-27
Abstract: Disclosed is a method of operating an on-demand water heater. The water heater has a first heater, a second heater, and a flow rate detector, the second heater being controllable and operating at lower flow rates than the first. The method includes: detecting the initiation of water flow; turning the first and second heaters on each at maximum power; detecting when the outlet flow of water reaches a predetermined temperature threshold; and monitoring the water flow rate. The method then includes detecting whether the water flow rate is below a first predetermined low flow threshold, and if so, turning the first heater off.
Patent NZ-590800-A (NZ)
Title: Compositions for treating rosacea comprising chitosan and a dicarboxylic acid
Inventor: MAILLAND FEDERICO
IPC: A61K9/00
Filed: 2009-07-28
Abstract: Disclosed is a pharmaceutical composition which is useful for protecting skin, and which comprises: (A) at least one of chitosan, a hydroxyalkyl chitosan and/or a physiologically acceptable salt thereof, and; (B) at least one linear and/or alkyl C6-C12-dicarboxylic acid amide of formula: ROC-(CH2)n-COR, wherein: n is an integer of between 4 and 10; R is N(R')(R'') group; R' is H or alkyl; R'' is H, alkyl or a C1-C4-carboxy group; and/or a physiologically acceptable salt thereof, and wherein component B is preferably selected from a compound such as potassium azeloyl diglycinate, diglycine azelate and / or a derivative thereof. Further disclosed is a composition as defined above for the treatment and/or prevention of rosacea, or for the treatment and/or prevention of telangiectasia.
Patent NZ-593493-A (NZ)
Title: Process for the preparation of optically active compounds using transfer hydrogenation
Inventor: MATHES CHRISTIAN
IPC: C07C213/08
Filed: 2009-12-23
Abstract: Disclosed isa catalytic process for the preparation of optically active compounds of formula (I) and their conversion thereafter to desired drag substances. In particular, the process relates to the preparation of (S)-3-(1-Dimethylamino-ethyl)-phenol using asymmetric catalytic reduction and transfer hydrogenation, thereby providing an improved route to forming drug substances such as rivastigimine and rivastigimine hydrogen tartrate.
Patent NZ-600216-A (NZ)
Title: Structural element
Inventor: WOOLF KEITH
IPC: E04C3/07
Filed: 2010-11-16
Abstract: 600216 A structural element comprising a web, a pair of substantially oppositely directed flanges projecting outwardly from respective ends of the web, wherein the web comprises two or more arcuate symmetrical channels formed therein, and wherein at least two of the two or more channels project into the web in opposed orientation to one another. Alternatively the element may have flanges oriented in same direction away from web with channels in web projecting in opposite directions. Other embodiments are disclosed.
Patent NZ-601352-A (NZ)
Title: Organically chelated mineral compositions and methods thereof
Inventor: LAMB MYRRA ARLENE
IPC: A23K1/175
Filed: 2010-07-13
Abstract: Disclosed is a method of making a mineral product, comprising: contacting a carboxylic acid and an inorganic mineral compound, sufficient to form a solution; reacting the solution over a period of time, sufficient to provide a mineral chelated compound; transferring the mineral chelated compound to one or more molds , prior to the compound substantially solidifying; and reducing the size of the mineral lactate compound, sufficient to provide a rapidly soluble mineral chelated product.